Name | [1-{[1-(4-Bromobenzyl)-1H-imidazol-5-yl]methyl}-4-(1-naphthyl)-1H -pyrrol-3-yl](4-morpholinyl)methanone |
---|---|
Synonyms |
[1-{[1-(4-Bromobenzyl)-1H-imidazol-5-yl]methyl}-4-(1-naphthyl)-1H-pyrrol-3-yl](4-morpholinyl)methanone
Methanone, [1-[[1-[(4-bromophenyl)methyl]-1H-imidazol-5-yl]methyl]-4-(1-naphthalenyl)-1H-pyrrol-3-yl]-4-morpholinyl- LB42708 |
Description | LB42708 is a potent, selective and orally active farnesyltransferase inhibitor. LB42708 inhibits farnesylation of H-Ras, N-Ras and K-Ras4B with IC50s of 0.8 nM, 1.2 nM and 2.0 nM, respectively[1]. |
---|---|
Related Catalog | |
In Vitro | LB42708 induces cell death despite K-ras prenylation. Growth inhibition by LB42708 is accompanied by G1 and G2/M cell cycle arrests in H-ras and K-ras-transformed RIE cells, respectively. LB42708 induces the upregulation of p21(CIP1/WAF1) and RhoB above the basal level that leads to the cell cycle arrest and to distinct morphological alterations of ras-transformed rat intestinal epithelial (RIE) cells[2]. |
References |
Density | 1.4±0.1 g/cm3 |
---|---|
Boiling Point | 769.6±60.0 °C at 760 mmHg |
Molecular Formula | C30H27BrN4O2 |
Molecular Weight | 555.465 |
Flash Point | 419.2±32.9 °C |
Exact Mass | 554.131714 |
PSA | 52.29000 |
LogP | 3.14 |
Vapour Pressure | 0.0±2.6 mmHg at 25°C |
Index of Refraction | 1.681 |
Storage condition | -20℃ |